Related references
Note: Only part of the references are listed.Regeneration Defects in Yap and Taz Mutant Mouse Livers Are Caused by Bile Duct Disruption and Cholestasis
Elisabeth Verboven et al.
GASTROENTEROLOGY (2021)
YAP Partially Reprograms Chromatin Accessibility to Directly Induce Adult Cardiogenesis In Vivo
Tanner O. Monroe et al.
DEVELOPMENTAL CELL (2019)
Biological mechanisms and related natural modulators of liver X receptor in nonalcoholic fatty liver disease
Mingzhu Ni et al.
BIOMEDICINE & PHARMACOTHERAPY (2019)
Hepatocyte Nuclear Factor 4-Alpha Is Essential for the Active Epigenetic State at Enhancers in Mouse Liver
Avinash Thakur et al.
HEPATOLOGY (2019)
A Non-canonical Role of YAP/TEAD Is Required for Activation of Estrogen-Regulated Enhancers in Breast Cancer
Chi Zhu et al.
MOLECULAR CELL (2019)
Hippo signalling during development
John Robert Davis et al.
DEVELOPMENT (2019)
The Hippo Signaling Pathway in Development and Disease
Yonggang Zheng et al.
DEVELOPMENTAL CELL (2019)
YAP and TAZ are dispensable for physiological and malignant haematopoiesis
Elisa Donato et al.
LEUKEMIA (2018)
YAP-TEAD signaling promotes basal cell carcinoma development via a c-JUN/AP1 axis
Dejan Maglic et al.
EMBO JOURNAL (2018)
Transcriptional addiction in cancer cells is mediated by YAP/TAZ through BRD4
Francesca Zanconato et al.
NATURE MEDICINE (2018)
Comprehensive Molecular Characterization of the Hippo Signaling Pathway in Cancer
Yumeng Wang et al.
CELL REPORTS (2018)
Hippo pathway coactivators Yap and Taz are required to coordinate mammalian liver regeneration
Li Lu et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2018)
Yes-Associated Protein/TEA Domain Family Member and Hepatocyte Nuclear Factor 4-Alpha (HNF4α) Repress Reciprocally to Regulate Hepatocarcinogenesis in Rats and Mice
Wang-Yu Cai et al.
HEPATOLOGY (2017)
Transcriptional integration of mitogenic and mechanical signals by Myc and YAP
Ottavio Croci et al.
GENES & DEVELOPMENT (2017)
An improved ATAC-seq protocol reduces background and enables interrogation of frozen tissues
M. Ryan Corces et al.
NATURE METHODS (2017)
Inactivation of Hippo Pathway Is Significantly Associated with Poor Prognosis in Hepatocellular Carcinoma
Bo Hwa Sohn et al.
CLINICAL CANCER RESEARCH (2016)
Actin remodeling confers BRAF inhibitor resistance to melanoma cells through YAP/TAZ activation
Min Hwan Kim et al.
EMBO JOURNAL (2016)
Induction of Expandable Tissue-Specific Stem/Progenitor Cells through Transient Expression of YAP/TAZ
Tito Panciera et al.
Cell Stem Cell (2016)
A YAP/TAZ-induced feedback mechanism regulates Hippo pathway homeostasis
Toshiro Moroishi et al.
GENES & DEVELOPMENT (2015)
YAP Drives Growth by Controlling Transcriptional Pause Release from Dynamic Enhancers
Giorgio G. Galli et al.
MOLECULAR CELL (2015)
Genome-wide association between YAP/TAZ/TEAD and AP-1 at enhancers drives oncogenic growth
Francesca Zanconato et al.
NATURE CELL BIOLOGY (2015)
The Hippo effector YAP promotes resistance to RAF- and MEK-targeted cancer therapies
Luping Lin et al.
NATURE GENETICS (2015)
YAP Inhibition Restores Hepatocyte Differentiation in Advanced HCC, Leading to Tumor Regression
Julien Fitamant et al.
CELL REPORTS (2015)
YAP1 Exerts Its Transcriptional Control via TEAD-Mediated Activation of Enhancers
Claudia Stein et al.
PLOS GENETICS (2015)
Cytokines and chemokines: At the crossroads of cell signalling and inflammatory disease
Mark D. Turner et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2014)
KRAS and YAP1 Converge to Regulate EMT and Tumor Survival
Diane D. Shao et al.
CELL (2014)
Hippo Pathway Activity Influences Liver Cell Fate
Dean Yimlamai et al.
CELL (2014)
YAP activation is an early event and a potential therapeutic target in liver cancer development
Andrea Perra et al.
JOURNAL OF HEPATOLOGY (2014)
Hippo Signaling Influences HNF4A and FOXA2 Enhancer Switching during Hepatocyte Differentiation
Olivia Alder et al.
CELL REPORTS (2014)
Switch Enhancers Interpret TGF-β and Hippo Signaling to Control Cell Fate in Human Embryonic Stem Cells
Tobias A. Beyer et al.
CELL REPORTS (2013)
The Hippo pathway and human cancer
Kieran F. Harvey et al.
NATURE REVIEWS CANCER (2013)
Regulation of the Hippo-YAP Pathway by G-Protein-Coupled Receptor Signaling
Fa-Xing Yu et al.
CELL (2012)
Role of TAZ as Mediator of Wnt Signaling
Luca Azzolin et al.
CELL (2012)
Yes-associated protein regulates the hepatic response after bile duct ligation
Haibo Bai et al.
HEPATOLOGY (2012)
The Hippo pathway target, YAP, promotes metastasis through its TEAD-interaction domain
John M. Lamar et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Members of the TEAD family of transcription factors regulate the expression of Myf5 in ventral somitic compartments
Ricardo Ribas et al.
DEVELOPMENTAL BIOLOGY (2011)
Role of YAP/TAZ in mechanotransduction
Sirio Dupont et al.
NATURE (2011)
The Merlin/NF2 Tumor Suppressor Functions through the YAP Oncoprotein to Regulate Tissue Homeostasis in Mammals
Nailing Zhang et al.
DEVELOPMENTAL CELL (2010)
The Hippo Signaling Pathway in Development and Cancer
Duojia Pan
DEVELOPMENTAL CELL (2010)
Mammalian Mst1 and Mst2 kinases play essential roles in organ size control and tumor suppression
Hai Song et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Hippo signaling is a potent in vivo growth and tumor suppressor pathway in the mammalian liver
Li Lu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
The Hippo-Salvador pathway restrains hepatic oval cell proliferation, liver size, and liver tumorigenesis
Kwang-Pyo Lee et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Mst1 and Mst2 Maintain Hepatocyte Quiescence and Suppress Hepatocellular Carcinoma Development through Inactivation of the Yap1 Oncogene
Dawang Zhou et al.
CANCER CELL (2009)
YAP1 increases organ size and expands undifferentiated progenitor cells
Fernando D. Camargo et al.
CURRENT BIOLOGY (2007)
Elucidation of a universal size-control mechanism in Drosophila and mammals
Jixin Dong et al.
CELL (2007)
Transforming properties of YAP, a candidate oncogene on the chromosome 11q22 amplicon
Michael Overholtzer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Identification and validation of oncogenes in liver cancer using an integrative oncogenomic approach
Lars Zender et al.
CELL (2006)
Gene Expression Omnibus: NCBI gene expression and hybridization array data repository
R Edgar et al.
NUCLEIC ACIDS RESEARCH (2002)
Hepatocyte nuclear factor 4α (nuclear receptor 2A1) is essential for maintenance of hepatic gene expression and lipid homeostasis
GP Hayhurst et al.
MOLECULAR AND CELLULAR BIOLOGY (2001)
Share Paper
